Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00132704 · ClinicalTrials.gov registry record
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 149
- Enrollment target
NCT00132704: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00132704 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 149 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00132704 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 149 participants
- Enrollment target
Study Summary
Doctors will take some tissue from the tissue removed during surgery in order to study how the blood vessels of the tumor respond to radiation therapy. The tissue obtained will be used to determine how these tumor blood vessels respond to radiation therapy delivered to the tumor, after it has been removed. This radiation is delivered in the research lab. This research is being conducted in order to develop new methods to treat tumors by radiation therapy. No additional surgery will be performed to obtain these samples, and only materials that remain after all diagnostic testing has been completed will be used.
Interventions
- RADIATION Ionizing radiation (IR) therapy
- RADIATION Ionizing radiation (IR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2004-08 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00132704
The ClinicalTrials.gov registry entry for NCT00132704 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ionizing radiation (IR) therapy is the first listed.
NCT00132704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00132704 about?
NCT00132704 is a clinical study titled "An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation". Doctors will take some tissue from the tissue removed during surgery in order to study how the blood vessels of the tumor respond to radiation therapy. The tissue obtained will be used to determine how these tumor blood vessels respond to radiation therapy delivered to the tumor, after it has been r...
What is the current status of trial NCT00132704?
This trial is currently completed. The enrollment target is 149 participants. The study started on 2004-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00132704?
The interventions under investigation include: Ionizing radiation (IR) therapy (RADIATION), Ionizing radiation (IR) (RADIATION).
Who is sponsoring clinical trial NCT00132704?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.